412 |
[2022 Jan;46(1)] Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study)
|
|
2022.07.15 |
276 |
411 |
[2022 Jan;46(1)] Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial
|
|
2022.07.15 |
289 |
410 |
[2022 Jan;46(1)] Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 Inhibitors
|
|
2022.07.15 |
271 |
409 |
[2022 Jan;46(1)] Association between Variability of Metabolic Risk Factors and Cardiometabolic Outcomes
|
|
2022.07.15 |
230 |
408 |
[2022 Jan;46(1)] Regulation of Pancreatic β-Cell Mass by Gene-Environment Interaction
|
|
2022.07.15 |
256 |
407 |
[2022 Jan;46(1)] Insulin Resistance: From Mechanisms to Therapeutic Strategies
|
|
2022.07.15 |
277 |
406 |
[2022 Jan;46(1)] Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications
|
|
2022.07.15 |
259 |
405 |
[2021 Nov;45(6)] Short-Term Effects of the Internet-Based Korea Diabetes Prevention Study: 6-Month Results of a Community-Based Randomized Controlled Trial
|
|
2022.07.15 |
278 |
404 |
[2021 Nov;45(6)] Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus
|
|
2022.07.15 |
283 |
403 |
[2021 Nov;45(6)] Dulaglutide as an Effective Replacement for Prandial Insulin in Kidney Transplant Recipients with Type 2 Diabetes Mellitus: A Retrospective Review
|
|
2022.07.15 |
273 |
402 |
[2021 Nov;45(6)] Carnitine Orotate Complex Ameliorates Insulin Resistance and Hepatic Steatosis Through Carnitine Acetyltransferase Pathway
|
|
2022.07.15 |
248 |
401 |
[2021 Nov;45(6)] Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway
|
|
2022.07.15 |
313 |
400 |
[2021 Nov;45(6)] Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
|
|
2022.07.15 |
253 |
399 |
[2021 Nov;45(6)] The rs2304256 Polymorphism in TYK2 Gene Is Associated with Protection for Type 1 Diabetes Mellitus
|
|
2022.07.15 |
269 |
398 |
[2021 Nov;45(6)] Increased Visit-to-Visit Liver Enzyme Variability Is Associated with Incident Diabetes: A Community-Based 12-Year Prospective Cohort Study
|
|
2022.07.15 |
292 |
397 |
[2021 Nov;45(6)] Trends and Risk Factors of Metabolic Syndrome among Korean Adolescents, 2007 to 2018
|
|
2022.07.15 |
241 |
396 |
[2021 Nov;45(6)] Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
|
|
2022.07.15 |
284 |
395 |
[2021 Nov;45(6)] Mitochondrial TFAM as a Signaling Regulator between Cellular Organelles: A Perspective on Metabolic Diseases
|
|
2022.07.15 |
238 |
394 |
[2021 Nov;45(6)] Brown Fat as a Regulator of Systemic Metabolism beyond Thermogenesis
|
|
2022.07.15 |
251 |
393 |
[2021 Nov;45(6)] Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence
|
|
2022.07.15 |
267 |